Indian API manufacturers solving formulation challenges
Better product basket for global markets
As new chemical elements have entered the pipeline as drug formulator, challenges have amplified. API manufacturers are pressed for meeting the increased demands to produce a potent product basket. Indian companies are solving formulating challenges with ingredients having better solubility levels. In some cases, the bioavailability and the therapeutic values have correspondingly improved. The actual challenge, however, lies in not disturbing the chemical entity while creating the API.
Oceanic Pharma employs experienced experts, in its strict approach to in-demand formulations. As a reputed Benfotiamine API manufacturer and a creator for flexible solutions, it responds to the requirements of buyers in the global markets.
How new opportunities are being addressed?
Various prospects can only be addressed by keeping pace with developments in the global pharma sector and creating the same environment at the testing stage. Currently, API creations are in a continuous process of growth. New diseases and viruses prompt the need for efficiency and provide opportunities to assemble active ingredients. The key to offering better products is also dependent on leveraging technology within the laboratory for productivity. API manufacturers in India are establishing the infrastructure and teams to fulfill demands.
Smart formulation & avoiding last-mile failures
The need for developing (components) for drugs to tackle healthcare problems requires scaling at different stages. Without any disregard to regulations, the impact of new APIs needs to be cost-effective to the buyer. The smart formulation is related to addressing failures at the last mile stage to make clinical trials successful. However, production ability is risky as innovations are always needed for better results. They are riddled with issues pertaining to:
The above issues depend on smart formulation approach for any API manufacturer to scale the business. They have to control risks at the testing stage to ensure that the processing does not impact vitro profiles. Often failures cost time and money when there is a repetition of a trial, or expanded clinical study. It also further delays the delivery of the drug into the market .
Modern innovative approach
Streamlining the production with a systematic approach is important to any product development. Oceanic Pharma with its deep knowledge and understanding of formulations, enables customers to implement solutions faster, and in turn products hit the shelves on time.
As we work with a global team of scientists and chemists, who are well versed in digital technologies, resulting in quicker turnaround times for reviews and approvals . The company diligently works on safe and significant ingredients for platforms like:
OPPL has an active product basket that caters to several healthcare pharma clients across the world. Our team is prepared to accept challenges and customize services and offerings as per every client needs.
Oceanic Pharma has decentralized and established units for manufacturing Rivastigmine, Rotigotin, Varenciline, Vonoprazan and Benfotiamine APIs. As no one size that fits each drug company stipulation, we create niche solutions. Check out our product basket to know how we have succeeded in the active pharma market worldwide.